Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boelaert

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|May 1, 1981
Should clearance be normalised to body surface or to lean body mass?T H Hallynck, H H Soep, J A Thomis, et al.
Nephron|January 1, 1989
Deferoxamine does not increase the risk for bacteremia in hemodialysis patientsC Tielemans, J Boelaert, P Vergauwe, et al.
Calcified Tissue International|January 1, 1982
Etiology of hypercalcemia in a patient with Addison's diseaseE Muls, R Bouillon, J Boelaert, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1985
The pharmacokinetics of ciprofloxacin in patients with impaired renal functionJ Boelaert, Y Valcke, M Schurgers, et al.
British Medical Journal|October 11, 1980
Sulphinpyrazone in acute myocardial infarctionP Lijnen, L J Verschueren, A Amery, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 1, 1982
Prostaglandin-kallikrein-renin system during acute sulphinpyrazone administration in healthy volunteersL J Verschueren, J Boelaert, R Daneels, et al.
Acta Clinica Belgica|January 1, 1987
Relapsing fever imported into Belgium: a case reportJ L Rummens, A Louwagie, A Van Hoof, et al.
Clinical Nephrology|May 1, 1986
Case report of renal failure during norfloxacin therapyJ Boelaert, P P de Jaegere, R Daneels, et al.
Drugs|January 1, 1985
Effect of renal function and dialysis on temocillin pharmacokineticsJ Boelaert, R Daneels, M Schurgers, et al.
The New England Journal of Medicine|November 5, 1981
Renal dysfunction due to anturaneJ Boelaert, P Van Eeghem, R Daneels, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|May 1, 1981
Should clearance be normalised to body surface or to lean body mass?T H Hallynck, H H Soep, J A Thomis, et al.
Nephron|January 1, 1989
Deferoxamine does not increase the risk for bacteremia in hemodialysis patientsC Tielemans, J Boelaert, P Vergauwe, et al.
Calcified Tissue International|January 1, 1982
Etiology of hypercalcemia in a patient with Addison's diseaseE Muls, R Bouillon, J Boelaert, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1985
The pharmacokinetics of ciprofloxacin in patients with impaired renal functionJ Boelaert, Y Valcke, M Schurgers, et al.
British Medical Journal|October 11, 1980
Sulphinpyrazone in acute myocardial infarctionP Lijnen, L J Verschueren, A Amery, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 1, 1982
Prostaglandin-kallikrein-renin system during acute sulphinpyrazone administration in healthy volunteersL J Verschueren, J Boelaert, R Daneels, et al.
Acta Clinica Belgica|January 1, 1987
Relapsing fever imported into Belgium: a case reportJ L Rummens, A Louwagie, A Van Hoof, et al.
Clinical Nephrology|May 1, 1986
Case report of renal failure during norfloxacin therapyJ Boelaert, P P de Jaegere, R Daneels, et al.
Drugs|January 1, 1985
Effect of renal function and dialysis on temocillin pharmacokineticsJ Boelaert, R Daneels, M Schurgers, et al.
The New England Journal of Medicine|November 5, 1981
Renal dysfunction due to anturaneJ Boelaert, P Van Eeghem, R Daneels, et al.
Pageof 7